ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”

June 17, 2011

CCRAC Shoots Down Two Projects, Approves Others

December 15, 1978

Minority Based CCOP RFA Generate Wide Interest; 44 Letters Of Intent Received for Eight Awards

September 1, 1989

Colon Polyps in Elderly Patients Are More Likely to Be Found Only with Colonoscopy

October 25, 2013

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982